Myocardial infarction (MI) occurs when an atherosclerotic plaque suddenly ruptures leading to formation of a thrombus that occludes a coronary artery. The resulting ischemia kills cardiomyocytes primarily through necrosis, much of which is mediated by opening of the mitochondrial permeability transition pore (mPTP) in the inner membrane.1 Standard treatment for ST-segment elevation MI (STEMI), the most damaging type of infarct, is to promptly restore myocardial perfusion by relieving the coronary obstruction, referred to as reperfusion. Although the net effect of reperfusion is to limit damage, 2 the reintroduction of oxygenated blood into an ischemic zone may induce substantial additional mPTPdependent necrosis, termed reperfusion injury.3 A recent article by Cung et al. reported that cyclosporine A, an inhibitor of mPTP opening, failed to lessen adverse outcomes from reperfusion injury. 4 This negative study is of interest because it raises important questions about mechanisms of cell death in MI and the creation of effective therapies to oppose them.Nowadays acute mortality from MI is 'only' 5-6%. 2 Most deaths result from a second problem known as heart failure, which develops over months to years following MI (Figure 1).Heart failure can be thought of as a weakening of the cardiac muscle that limits the effective delivery of blood to tissues throughout the body. Heart failure is one of the most common causes of death worldwide, and prior MIs are the etiology iñ 50% of cases. Importantly, the size of the acute infarction is the major determinant of adverse cardiac remodeling, heart failure, and patient death.5 Timely reperfusion of STEMI using angioplasty/stenting provides significant net reductions in infarct size and improvements in clinical outcomes.2 But, the benefits of this therapy are thought to be limited by reperfusion injury. Attempts to reduce reperfusion injury have been unsuccessful -possibly because of targeting of redundant death pathways or processes that lie downstream of the actual cell death event.Although traditionally considered passive and unregulated, recent work has established that necrosis in many contexts is actively mediated through two major pathways:6 (a) necroptosis, involving cell surface death receptors/RIPK1/RIPK3// MLKL1; and (b) mitochondrial-dependent necrosis, in which the sentinel event is Ca 2+ -induced opening of the mPTP. In healthy cells, mPTP is mostly in the closed state, which maintains the electrochemical gradient across the inner membrane (Δψ m ) required for ATP synthesis. Increased concentrations of Ca 2+ in the mitochondrial matrix, such as during ischemia, trigger opening of the pore, leading to: (a) loss of Δψ m with cessation of ATP synthesis; and (b) mitochondrial swelling and dysfunction due to influx of water into the soluterich matrix. Recent work suggests that the F0-F1 ATP synthase itself may be the channel-forming component of mPTP.
7Although not part of the channel, cyclophilin D, a peptidyl prolyl cis-trans isomerase, sensitizes the pore to Ca
2+...